INSULIN LISPRO-AABC

INSULIN LISPRO-AABC was reported 2106 times

INSULIN LISPRO-AABC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ATYPICAL DOSE RESPONSE RELATIONSHIP 1 0.5000
1 ORTHOSTATIC HEADACHE 2 0.1250
2 PEPTIC ULCER HELICOBACTER 1 0.0526
3 PERSISTENT POSTURAL-PERCEPTUAL DIZZINESS 2 0.0513
4 MEDICAL DEVICE SITE PRURITUS 1 0.0370
5 HEPATOBILIARY PROCEDURAL COMPLICATION 1 0.0357
6 INFUSION SITE HYPERSENSITIVITY 4 0.0333
7 VIIITH NERVE INJURY 2 0.0294
8 DIABETIC GLAUCOMA 1 0.0278
9 INFUSION SITE IRRITATION 33 0.0257
10 INFUSION SITE MASS 23 0.0212
11 BLOOD GLUCOSE FALSE POSITIVE 1 0.0208
12 INFUSION SITE PAIN 266 0.0206
13 PRODUCT REGIMEN CONFUSION 1 0.0192
14 PANCREATOGENOUS DIABETES 1 0.0154
15 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 1 0.0154
16 INFUSION SITE DISCOMFORT 15 0.0145
17 ACCESSORY AURICLE 1 0.0143
18 APPLICATION SITE FOLLICULITIS 1 0.0139
19 INFUSION SITE INDURATION 18 0.0121
20 ADMINISTRATION SITE INFLAMMATION 1 0.0111
21 ADMINISTRATION SITE INDURATION 1 0.0111
22 INFUSION SITE ULCER 1 0.0109
23 EYE OPACITY 1 0.0109
24 DIABETIC WOUND 1 0.0108
25 INFUSION SITE PRURITUS 33 0.0104
26 INFUSION SITE URTICARIA 7 0.0104
27 HYPERTELORISM 1 0.0101
28 INFUSION SITE RASH 12 0.0087
29 INFUSION SITE SCAB 1 0.0081
30 INFUSION SITE VESICLES 4 0.0076
31 NEUROPROSTHESIS IMPLANTATION 1 0.0072
32 THERAPEUTIC RESPONSE DELAYED 20 0.0071
33 FALLOPIAN TUBE CANCER 1 0.0069
34 GALLBLADDER OEDEMA 2 0.0068
35 INFUSION SITE SCAR 3 0.0068
36 INFUSION SITE BRUISING 14 0.0065
37 IMMUNE-MEDIATED NEUROPATHY 1 0.0065
38 INFUSION SITE HAEMORRHAGE 21 0.0064
39 INFUSION SITE ERYTHEMA 53 0.0063
40 INFUSION SITE INFLAMMATION 4 0.0057
41 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 3 0.0053
42 CERVIX HAEMORRHAGE UTERINE 1 0.0052
43 CATHETER SITE INDURATION 1 0.0052
44 CORTISOL ABNORMAL 1 0.0050
45 INFUSION SITE REACTION 15 0.0050
46 HEART VALVE CALCIFICATION 1 0.0050
47 DELUSIONAL PERCEPTION 2 0.0048
48 BACTERIAL DIARRHOEA 1 0.0047
49 HYPERINSULINAEMIC HYPOGLYCAEMIA 1 0.0045
50 INSULIN RESISTANCE 9 0.0043
51 PUNCTURE SITE PAIN 1 0.0043
52 PILONIDAL DISEASE 1 0.0042
53 INFUSION SITE ABSCESS 2 0.0040
54 ACETONAEMIA 1 0.0040
55 SPINAL INSTABILITY 1 0.0039
56 DRAIN PLACEMENT 1 0.0039
57 ACCIDENTAL UNDERDOSE 55 0.0038
58 EPIRETINAL MEMBRANE 1 0.0036
59 CHOLESTEATOMA 1 0.0036
60 MEDICAL DEVICE SITE PAIN 2 0.0036
61 DIABETIC GANGRENE 1 0.0035
62 LENS DISORDER 1 0.0035
63 LARGE FOR DATES BABY 3 0.0034
64 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1 0.0033
65 MALABSORPTION FROM INJECTION SITE 1 0.0032
66 INFUSION SITE NODULE 3 0.0031
67 NEUROPATHIC ARTHROPATHY 2 0.0031
68 ADMINISTRATION SITE SWELLING 1 0.0031
69 BLOOD GLUCOSE ABNORMAL 56 0.0030
70 BLOOD GLUCOSE INCREASED 566 0.0030
71 MEDULLARY THYROID CANCER 1 0.0029
72 STIFF PERSON SYNDROME 1 0.0029
73 TIME PERCEPTION ALTERED 1 0.0028
74 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
75 DIABETIC KETOSIS 1 0.0026
76 COLON CANCER STAGE III 1 0.0026
77 ALLERGIC COUGH 2 0.0026
78 HYPOGLYCAEMIC ENCEPHALOPATHY 1 0.0026
79 PANCREATOLITHIASIS 1 0.0025
80 ACOUSTIC NEUROMA 1 0.0024
81 HYDROTHORAX 2 0.0024
82 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
83 BLOOD HOMOCYSTEINE INCREASED 1 0.0023
84 ABDOMINAL LYMPHADENOPATHY 2 0.0023
85 OSTOMY BAG PLACEMENT 1 0.0022
86 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
87 PREGNANCY TEST FALSE POSITIVE 1 0.0021
88 BLOOD GLUCOSE DECREASED 103 0.0021
89 INJECTION SITE SCAR 6 0.0021
90 SHOCK HYPOGLYCAEMIC 1 0.0021
91 WRONG PATIENT RECEIVED PRODUCT 6 0.0020
92 DIABETIC RETINAL OEDEMA 1 0.0020
93 INFUSION SITE SWELLING 12 0.0019
94 BLOOD GASES ABNORMAL 1 0.0019
95 HYPERTROPHY 1 0.0018
96 SUPERFICIAL INJURY OF EYE 2 0.0018
97 GLYCOSYLATED HAEMOGLOBIN INCREASED 46 0.0018
98 PRESBYOPIA 1 0.0018
99 BLOOD GLUCOSE FLUCTUATION 19 0.0017
100 COLON CANCER STAGE IV 1 0.0017
101 RETINAL ISCHAEMIA 1 0.0016
102 WRONG PRODUCT ADMINISTERED 11 0.0016
103 VITAMIN D INCREASED 1 0.0016
104 PSOAS ABSCESS 1 0.0016
105 MONOCLONAL GAMMOPATHY 1 0.0016
106 PRODUCT STORAGE ISSUE 6 0.0016
107 HIV TEST POSITIVE 1 0.0015
108 CUTANEOUS SYMPTOM 1 0.0015
109 MONOCYTE PERCENTAGE INCREASED 1 0.0014
110 INJECTION SITE INFLAMMATION 7 0.0014
111 DIABETIC ULCER 1 0.0014
112 DYSLALIA 1 0.0014
113 MYASTHENIC SYNDROME 1 0.0013
114 INFUSION SITE INFECTION 3 0.0013
115 BLOOD KETONE BODY INCREASED 1 0.0013
116 MEDICAL DEVICE SITE DISCOMFORT 1 0.0012
117 PROCEDURAL NAUSEA 1 0.0012
118 GLYCOSYLATED HAEMOGLOBIN DECREASED 2 0.0012
119 WRONG DOSE 3 0.0012
120 REACTION TO PRESERVATIVES 1 0.0012
121 ACNE PUSTULAR 1 0.0012
122 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
123 KETOACIDOSIS 9 0.0012
124 INFECTED BITE 1 0.0012
125 ENZYME LEVEL INCREASED 1 0.0012
126 INTENTIONAL DEVICE USE ISSUE 1 0.0012
127 MYCOTIC ALLERGY 1 0.0012
128 CRANIOSYNOSTOSIS 1 0.0012
129 URGE INCONTINENCE 1 0.0011
130 ARTERIAL STENOSIS 1 0.0011
131 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
132 INJECTION SITE IRRITATION 14 0.0011
133 ABULIA 1 0.0011
134 RETINOPATHY 4 0.0011
135 PRODUCT AFTER TASTE 1 0.0010
136 INJECTION SITE DISCOMFORT 11 0.0010
137 HYPERGLYCAEMIA 38 0.0010
138 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
139 MUCOSAL DISORDER 1 0.0010
140 EYELID PAIN 2 0.0010
141 TRIGGER FINGER 4 0.0010
142 GASTRIC PH DECREASED 1 0.0010
143 FULMINANT TYPE 1 DIABETES MELLITUS 1 0.0010
144 INJECTION SITE HYPERSENSITIVITY 3 0.0010
145 URETEROLITHIASIS 1 0.0010
146 SINUSITIS BACTERIAL 1 0.0009
147 CARPAL TUNNEL DECOMPRESSION 1 0.0009
148 LIPODYSTROPHY ACQUIRED 2 0.0009
149 NEUROMYOPATHY 1 0.0009
150 VASCULAR CALCIFICATION 1 0.0009
151 PANCREATIC MASS 1 0.0009
152 IDIOPATHIC URTICARIA 1 0.0009
153 KETOSIS 1 0.0009
154 POST PROCEDURAL SWELLING 1 0.0009
155 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
156 OLIGOHYDRAMNIOS 3 0.0009
157 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
158 HYPOGLYCAEMIA 43 0.0009
159 DIABETIC RETINOPATHY 3 0.0009
160 MYOPIA 2 0.0008
161 DYSPLASIA 1 0.0008
162 REFLUX GASTRITIS 1 0.0008
163 INFUSION SITE WARMTH 1 0.0008
164 DEVICE INFUSION ISSUE 2 0.0008
165 INTERVERTEBRAL DISC OPERATION 1 0.0008
166 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
167 INJECTION SITE ABSCESS 2 0.0008
168 ALLERGY TO CHEMICALS 1 0.0008
169 NEUTROPHIL PERCENTAGE INCREASED 1 0.0008
170 HYPERAESTHESIA TEETH 1 0.0008
171 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 160 0.0008
172 PHYSICAL DECONDITIONING 2 0.0008
173 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
174 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
175 MACULAR HOLE 1 0.0007
176 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
177 INJECTION SITE PAIN 224 0.0007
178 BILIARY TRACT DISORDER 1 0.0007
179 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
180 CEREBRAL THROMBOSIS 2 0.0007
181 CONNECTIVE TISSUE DISORDER 1 0.0007
182 PANCREATIC CARCINOMA METASTATIC 2 0.0007
183 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
184 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
185 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
186 COCCYDYNIA 1 0.0007
187 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
188 CHOLANGIOCARCINOMA 1 0.0007
189 HYPERCAPNIA 2 0.0007
190 EXPIRED PRODUCT ADMINISTERED 22 0.0007
191 INCORRECT DOSE ADMINISTERED 148 0.0006
192 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
193 HUNGER 9 0.0006
194 HYPOTONIA NEONATAL 1 0.0006
195 SKIN REACTION 9 0.0006
196 TRANSCRIPTION MEDICATION ERROR 1 0.0006
197 PRE-ECLAMPSIA 3 0.0006
198 COLON CANCER METASTATIC 1 0.0006
199 HYPOGLYCAEMIA NEONATAL 1 0.0006
200 OPTIC ATROPHY 1 0.0006
201 DIABETIC NEUROPATHY 3 0.0006
202 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
203 HEPATIC FIBROSIS 2 0.0006
204 FOETAL DEATH 3 0.0006
205 HYPOPITUITARISM 1 0.0006
206 PSEUDOMONAL SEPSIS 1 0.0006
207 INFUSION SITE DISCHARGE 1 0.0006
208 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
209 HAEMORRHAGE 57 0.0005
210 OESOPHAGEAL SPASM 1 0.0005
211 INJECTION SITE INJURY 3 0.0005
212 NASAL OBSTRUCTION 1 0.0005
213 INFECTED SKIN ULCER 1 0.0005
214 AUTOIMMUNE THYROIDITIS 2 0.0005
215 ADRENAL DISORDER 1 0.0005
216 ATROPHY 1 0.0005
217 INJECTION SITE MASS 19 0.0005
218 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
219 PHARYNGEAL SWELLING 5 0.0005
220 SKIN ODOUR ABNORMAL 2 0.0005
221 VISUAL IMPAIRMENT 63 0.0005
222 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
223 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
224 OESOPHAGEAL CANDIDIASIS 2 0.0005
225 DIABETIC KETOACIDOSIS 12 0.0005
226 TYPE 1 DIABETES MELLITUS 3 0.0005
227 PERIPHERAL VENOUS DISEASE 2 0.0005
228 GOITRE 2 0.0005
229 VENOUS THROMBOSIS LIMB 1 0.0005
230 DEVICE CONNECTION ISSUE 1 0.0005
231 VASCULAR OCCLUSION 1 0.0005
232 EYE CONTUSION 1 0.0005
233 TONGUE DISCOMFORT 2 0.0005
234 CARDIAC FAILURE CHRONIC 2 0.0005
235 OCULOGYRIC CRISIS 1 0.0005
236 GASTRIC BYPASS 1 0.0005
237 LIMB MASS 1 0.0005
238 THIRST 8 0.0004
239 FEAR OF DEATH 1 0.0004
240 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
241 PERIARTHRITIS 1 0.0004
242 READING DISORDER 1 0.0004
243 UTERINE DISORDER 1 0.0004
244 INJECTION SITE BRUISING 34 0.0004
245 INJECTION SITE RASH 13 0.0004
246 RADIUS FRACTURE 1 0.0004
247 GASTROINTESTINAL OBSTRUCTION 1 0.0004
248 INCORRECT DOSAGE ADMINISTERED 2 0.0004
249 HAEMATOLOGICAL INFECTION 1 0.0004
250 INFREQUENT BOWEL MOVEMENTS 1 0.0004
251 VASODILATATION 1 0.0004
252 METASTASES TO PERITONEUM 1 0.0004
253 RETINAL ARTERY OCCLUSION 1 0.0004
254 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
255 APPENDICITIS PERFORATED 1 0.0004
256 HAEMORRHAGE URINARY TRACT 1 0.0004
257 INJECTION SITE REACTION 27 0.0004
258 MENOPAUSE 1 0.0004
259 INJECTION SITE HAEMORRHAGE 31 0.0004
260 CATHETER SITE PAIN 1 0.0004
261 RETINAL DISORDER 1 0.0004
262 PULMONARY HAEMORRHAGE 3 0.0004
263 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
264 INJECTION SITE PRURITUS 25 0.0004
265 LARYNGOSPASM 1 0.0004
266 SKIN DISCOMFORT 1 0.0004
267 EAR CONGESTION 1 0.0004
268 IMPAIRED GASTRIC EMPTYING 5 0.0004
269 PRODUCT STORAGE ERROR 32 0.0004
270 THYROID NEOPLASM 1 0.0004
271 CYSTIC FIBROSIS 2 0.0004
272 HAEMATOLOGICAL MALIGNANCY 1 0.0004
273 PNEUMATOSIS INTESTINALIS 1 0.0004
274 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
275 ABORTION 1 0.0003
276 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
277 THYROIDITIS 1 0.0003
278 CRANIOCEREBRAL INJURY 1 0.0003
279 DISCOMFORT 20 0.0003
280 DIABETIC FOOT 1 0.0003
281 GENERALISED OEDEMA 4 0.0003
282 PANCREATIC CARCINOMA STAGE IV 1 0.0003
283 BREAST CANCER RECURRENT 1 0.0003
284 PHOTOPSIA 2 0.0003
285 BLADDER PAIN 1 0.0003
286 SCIATICA 5 0.0003
287 INCOHERENT 2 0.0003
288 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2 0.0003
289 HYPOVENTILATION 1 0.0003
290 TENDON DISORDER 2 0.0003
291 HYPOACUSIS 13 0.0003
292 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
293 LYME DISEASE 1 0.0003
294 DRY THROAT 3 0.0003
295 INJURY ASSOCIATED WITH DEVICE 6 0.0003
296 APLASIA PURE RED CELL 1 0.0003
297 CERVICAL VERTEBRAL FRACTURE 1 0.0003
298 INJECTION SITE URTICARIA 7 0.0003
299 BLINDNESS UNILATERAL 4 0.0003
300 JAUNDICE CHOLESTATIC 1 0.0003
301 INJECTION SITE ERYTHEMA 35 0.0003
302 PRODUCT DISPENSING ERROR 6 0.0003
303 FEELING DRUNK 2 0.0003
304 HYPERACUSIS 1 0.0003
305 FACE INJURY 1 0.0003
306 PARANASAL SINUS HYPERSECRETION 1 0.0003
307 ERUCTATION 5 0.0003
308 PANIC DISORDER 1 0.0003
309 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
310 FAECES HARD 1 0.0003
311 CERVIX CARCINOMA 1 0.0003
312 ORAL INFECTION 1 0.0003
313 WOUND SECRETION 1 0.0003
314 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
315 EXPOSURE VIA BREAST MILK 1 0.0003
316 CEREBRAL ATROPHY 1 0.0003
317 HYPERPHAGIA 1 0.0003
318 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
319 ENURESIS 1 0.0002
320 PRESYNCOPE 6 0.0002
321 FEEDING DISORDER 5 0.0002
322 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
323 DECUBITUS ULCER 2 0.0002
324 HICCUPS 2 0.0002
325 HYPERURICAEMIA 1 0.0002
326 LEG AMPUTATION 1 0.0002
327 PRODUCT DOSE OMISSION ISSUE 71 0.0002
328 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
329 ABSCESS LIMB 1 0.0002
330 PRODUCT DISPENSING ISSUE 1 0.0002
331 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
332 MELANOCYTIC NAEVUS 1 0.0002
333 ABDOMINAL ABSCESS 1 0.0002
334 FACIAL PAIN 2 0.0002
335 VASCULAR DEVICE INFECTION 1 0.0002
336 END STAGE RENAL DISEASE 4 0.0002
337 CATARACT 13 0.0002
338 RETINAL DETACHMENT 2 0.0002
339 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
340 LOCALISED OEDEMA 1 0.0002
341 RENAL FUNCTION TEST ABNORMAL 1 0.0002
342 PERFORMANCE STATUS DECREASED 1 0.0002
343 SEASONAL ALLERGY 3 0.0002
344 SPINAL DISORDER 2 0.0002
345 GESTATIONAL DIABETES 1 0.0002
346 PARALYSIS 3 0.0002
347 LIMB OPERATION 1 0.0002
348 KIDNEY TRANSPLANT REJECTION 1 0.0002
349 HUMERUS FRACTURE 1 0.0002
350 GUILLAIN-BARRE SYNDROME 1 0.0002
351 HORMONE LEVEL ABNORMAL 1 0.0002
352 HEPATOMEGALY 2 0.0002
353 PANCREATIC DISORDER 1 0.0002
354 HYPERVOLAEMIA 1 0.0002
355 APPLICATION SITE SWELLING 1 0.0002
356 HYPERAMMONAEMIA 1 0.0002
357 THYROID DISORDER 3 0.0002
358 PERIPHERAL VASCULAR DISORDER 1 0.0002
359 SKIN NECROSIS 1 0.0002
360 SWOLLEN TONGUE 6 0.0002
361 MALABSORPTION 1 0.0002
362 PARTIAL SEIZURES 1 0.0002
363 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
364 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
365 OVERWEIGHT 1 0.0002
366 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
367 INJECTION SITE DISCHARGE 1 0.0002
368 BURNING SENSATION 13 0.0002
369 MUSCLE TIGHTNESS 3 0.0002
370 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
371 ASTHENOPIA 1 0.0002
372 INTESTINAL ISCHAEMIA 1 0.0002
373 DEAFNESS UNILATERAL 1 0.0002
374 MACULAR OEDEMA 1 0.0002
375 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
376 ILLNESS 18 0.0002
377 MOUTH SWELLING 1 0.0002
378 ENTEROCOLITIS 1 0.0002
379 PANCREATIC CARCINOMA 5 0.0002
380 METABOLIC DISORDER 1 0.0002
381 VASCULITIS 2 0.0002
382 DYSSTASIA 5 0.0002
383 URINE ODOUR ABNORMAL 1 0.0002
384 DRUG INEFFECTIVE 224 0.0002
385 ATAXIA 2 0.0002
386 CATARACT OPERATION 1 0.0002
387 CHOLECYSTITIS 2 0.0002
388 MACULAR DEGENERATION 2 0.0002
389 OSTEOMYELITIS 3 0.0002
390 MENISCUS INJURY 1 0.0002
391 EYE SWELLING 6 0.0002
392 INFUSION SITE EXTRAVASATION 1 0.0002
393 INJECTION SITE DISCOLOURATION 2 0.0002
394 SWELLING OF EYELID 1 0.0002
395 BRAIN OEDEMA 2 0.0002
396 CYSTITIS 5 0.0002
397 FOREIGN BODY SENSATION IN EYES 1 0.0002
398 INJECTION SITE SWELLING 12 0.0002
399 HYPOPHAGIA 4 0.0002
400 MYDRIASIS 2 0.0002
401 CONTUSION 15 0.0002
402 GLAUCOMA 3 0.0002
403 POLYP 1 0.0002
404 APPETITE DISORDER 1 0.0002
405 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
406 COGNITIVE DISORDER 7 0.0001
407 EYE HAEMORRHAGE 2 0.0001
408 NEOPLASM MALIGNANT 10 0.0001
409 TERMINAL STATE 1 0.0001
410 LIMB INJURY 4 0.0001
411 NEPHROTIC SYNDROME 1 0.0001
412 ONYCHOCLASIS 1 0.0001
413 RESPIRATION ABNORMAL 1 0.0001
414 JOINT EFFUSION 1 0.0001
415 LYMPHOEDEMA 1 0.0001
416 ORAL DISCOMFORT 2 0.0001
417 FORMICATION 1 0.0001
418 COORDINATION ABNORMAL 2 0.0001
419 EXTRASYSTOLES 1 0.0001
420 DEMENTIA 4 0.0001
421 MASS 2 0.0001
422 WOUND 4 0.0001
423 PULMONARY TOXICITY 1 0.0001
424 HAND FRACTURE 1 0.0001
425 RETCHING 3 0.0001
426 PRODUCT SUPPLY ISSUE 1 0.0001
427 PANIC REACTION 1 0.0001
428 HYPOKINESIA 2 0.0001
429 GASTROENTERITIS 2 0.0001
430 ASCITES 4 0.0001
431 INFLAMMATION 7 0.0001
432 BLINDNESS TRANSIENT 1 0.0001
433 SENSITIVE SKIN 1 0.0001
434 LIVER DISORDER 6 0.0001
435 CEREBRAL DISORDER 1 0.0001
436 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
437 BLOOD POTASSIUM DECREASED 4 0.0001
438 LOSS OF CONSCIOUSNESS 17 0.0001
439 HEPATOCELLULAR CARCINOMA 1 0.0001
440 SKIN IRRITATION 6 0.0001
441 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
442 ATRIOVENTRICULAR BLOCK 1 0.0001
443 LIMB DISCOMFORT 4 0.0001
444 ANKLE FRACTURE 2 0.0001
445 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
446 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
447 PRODUCT USE COMPLAINT 2 0.0001
448 PNEUMOTHORAX 2 0.0001
449 LOW BIRTH WEIGHT BABY 1 0.0001
450 ULCER 2 0.0001
451 HYPERHIDROSIS 16 0.0001
452 EYE PAIN 7 0.0001
453 LOCALISED INFECTION 3 0.0001
454 STENT PLACEMENT 1 0.0001
455 MYASTHENIA GRAVIS 1 0.0001
456 FRUSTRATION TOLERANCE DECREASED 1 0.0001
457 MUSCLE DISORDER 1 0.0001
458 POST PROCEDURAL INFECTION 1 0.0001
459 CHOLELITHIASIS 4 0.0001
460 HYPERAESTHESIA 1 0.0001
461 EYE DISORDER 4 0.0001
462 ESCHERICHIA INFECTION 1 0.0001
463 SPINAL COMPRESSION FRACTURE 1 0.0001
464 LIP SWELLING 4 0.0001
465 POLLAKIURIA 5 0.0001
466 GAIT INABILITY 4 0.0001
467 CIRCULATORY COLLAPSE 2 0.0001
468 DRUG RESISTANCE 3 0.0001
469 CARDIAC OPERATION 1 0.0001
470 BLOOD MAGNESIUM DECREASED 1 0.0001
471 NEUROPATHY PERIPHERAL 11 0.0001
472 HYSTERECTOMY 1 0.0001
473 THERAPEUTIC RESPONSE DECREASED 7 0.0001
474 ORTHOSTATIC HYPOTENSION 2 0.0001
475 JOINT STIFFNESS 3 0.0001
476 DEVICE USE ISSUE 2 0.0001
477 AMENORRHOEA 2 0.0001
478 MOBILITY DECREASED 8 0.0001
479 LOSS OF LIBIDO 1 0.0001
480 HEAVY MENSTRUAL BLEEDING 1 0.0001
481 HEART RATE INCREASED 11 0.0001
482 OROPHARYNGEAL DISCOMFORT 1 0.0001
483 OEDEMA 6 0.0001
484 HIDRADENITIS 1 0.0001
485 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
486 INCREASED TENDENCY TO BRUISE 1 0.0001
487 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
488 NERVE COMPRESSION 1 0.0001
489 NEPHROPATHY 1 0.0001
490 DIARRHOEA HAEMORRHAGIC 1 0.0001
491 PHOTOPHOBIA 2 0.0001
492 ARTERIOSCLEROSIS 1 0.0001
493 LEUKAEMIA 1 0.0001
494 FOOT FRACTURE 2 0.0001
495 POISONING DELIBERATE 1 0.0001
496 EYE INFLAMMATION 1 0.0001
497 SLEEP APNOEA SYNDROME 2 0.0001
498 INCREASED APPETITE 2 0.0001
499 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
500 LOWER LIMB FRACTURE 2 0.0001
501 AUTOIMMUNE DISORDER 1 0.0001
502 VITAMIN D DEFICIENCY 1 0.0001
503 COELIAC DISEASE 1 0.0001
504 MEMORY IMPAIRMENT 14 0.0001
505 VITREOUS FLOATERS 1 0.0001
506 BODY TEMPERATURE DECREASED 1 0.0001
507 UPPER LIMB FRACTURE 2 0.0001
508 SPINAL FRACTURE 2 0.0001
509 BRAIN INJURY 1 0.0001
510 LACRIMATION INCREASED 3 0.0001
511 EMPHYSEMA 1 0.0001
512 EXTRA DOSE ADMINISTERED 4 0.0001
513 TASTE DISORDER 2 0.0001
514 EYELID PTOSIS 1 0.0001
515 BODY TEMPERATURE INCREASED 2 0.0001
516 INITIAL INSOMNIA 1 0.0001
517 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
518 TOOTH LOSS 2 0.0001
519 SCRATCH 1 0.0001
520 JOINT DISLOCATION 1 0.0001
521 DEPRESSED MOOD 5 0.0001
522 FULL BLOOD COUNT ABNORMAL 1 0.0001
523 PHARYNGITIS STREPTOCOCCAL 1 0.0001
524 BACK INJURY 1 0.0001
525 CONSTIPATION 20 0.0001
526 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
527 ASPIRATION 1 0.0001
528 STAPHYLOCOCCAL INFECTION 3 0.0001
529 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
530 VENTRICULAR FIBRILLATION 1 0.0001
531 NERVE INJURY 1 0.0001
532 BLISTER 5 0.0001
533 FISTULA 1 0.0001
534 GAIT DISTURBANCE 17 0.0001
535 ANGER 3 0.0001
536 EYE INFECTION 1 0.0001
537 DERMATITIS CONTACT 1 0.0001
538 SCAB 1 0.0001
539 NEOPLASM 1 0.0001
540 GASTRIC HAEMORRHAGE 1 0.0001
541 EYE IRRITATION 5 0.0001
542 DEVICE USE ERROR 3 0.0001
543 DRY MOUTH 7 0.0001
544 RENAL DISORDER 4 0.0001
545 SPINAL PAIN 1 0.0001
546 SEXUAL DYSFUNCTION 1 0.0001
547 NASAL CONGESTION 5 0.0001
548 COVID-19 PNEUMONIA 1 0.0001
549 BACTERAEMIA 1 0.0001
550 PRODUCT PRESCRIBING ERROR 2 0.0001
551 THYROID CANCER 1 0.0001
552 MENTAL IMPAIRMENT 2 0.0001
553 NOCTURIA 1 0.0001
554 PANIC ATTACK 3 0.0001
555 NEURALGIA 2 0.0001
556 DYSURIA 3 0.0001
557 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
558 TENDON RUPTURE 1 0.0001
559 BALANCE DISORDER 7 0.0001
560 ABNORMAL WEIGHT GAIN 1 0.0001
561 SEPSIS 9 0.0001
562 PHARYNGITIS 1 0.0001
563 CYST 1 0.0001
564 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
565 HAIR COLOUR CHANGES 1 0.0001
566 VISION BLURRED 11 0.0001
567 DYSPNOEA EXERTIONAL 3 0.0001
568 COLITIS 3 0.0001
569 HAEMATEMESIS 2 0.0001
570 WEIGHT DECREASED 22 0.0001
571 DIABETES MELLITUS 6 0.0001
572 SINUSITIS 8 0.0001
573 ERECTILE DYSFUNCTION 2 0.0001
574 ROTATOR CUFF SYNDROME 1 0.0001
575 DECREASED APPETITE 18 0.0001
576 HAEMATOMA 2 0.0001
577 INJECTION SITE INDURATION 1 0.0001
578 DIPLOPIA 2 0.0001
579 RESPIRATORY TRACT INFECTION 2 0.0001
580 NODULE 1 0.0001
581 VOMITING 36 0.0001
582 BEDRIDDEN 1 0.0001
583 IMMUNE SYSTEM DISORDER 1 0.0001
584 PULMONARY CONGESTION 1 0.0001
585 SARS-COV-2 TEST POSITIVE 1 0.0001
586 BLOOD PRESSURE DECREASED 5 0.0001
587 DIZZINESS 37 0.0001
588 DISTURBANCE IN ATTENTION 4 0.0001
589 BLINDNESS 3 0.0001
590 PNEUMONITIS 2 0.0001
591 MIGRAINE 7 0.0001
592 DEVICE MECHANICAL ISSUE 1 0.0001
593 OSTEOPOROSIS 3 0.0001
594 PRURITUS 28 0.0001
595 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
596 PROCEDURAL PAIN 2 0.0001
597 FEELING COLD 2 0.0001
598 CARDIO-RESPIRATORY ARREST 3 0.0001
599 ROAD TRAFFIC ACCIDENT 3 0.0001
600 URTICARIA 12 0.0001
601 RENAL IMPAIRMENT 6 0.0001
602 CARPAL TUNNEL SYNDROME 1 0.0001
603 PERIPHERAL SWELLING 11 0.0001
604 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
605 FEELING ABNORMAL 17 0.0001
606 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
607 HYPERSENSITIVITY 13 0.0001
608 RED BLOOD CELL COUNT DECREASED 2 0.0001
609 HYPERSOMNIA 2 0.0001
610 SOMNOLENCE 14 0.0001
611 VAGINAL HAEMORRHAGE 3 0.0001
612 APATHY 1 0.0001
613 COVID-19 12 0.0001
614 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
615 URINARY INCONTINENCE 2 0.0001
616 SKIN HAEMORRHAGE 1 0.0001
617 COLON CANCER 1 0.0001
618 GASTROINTESTINAL DISORDER 6 0.0001
619 RESPIRATORY DISORDER 2 0.0001
620 HOT FLUSH 5 0.0001
621 HEPATIC FAILURE 2 0.0001
622 SUICIDE ATTEMPT 4 0.0001
623 OSTEOPENIA 1 0.0001
624 DEVICE FAILURE 1 0.0001
625 NEPHROLITHIASIS 3 0.0001
626 LYMPHOMA 1 0.0001
627 MUSCULOSKELETAL CHEST PAIN 1 0.0001
628 TENDONITIS 1 0.0001
629 NAUSEA 51 0.0001
630 BASAL CELL CARCINOMA 1 0.0001
631 BRAIN FOG 1 0.0001
632 CYANOSIS 1 0.0001
633 ARTHRITIS 5 0.0001
634 PAIN 39 0.0001
635 DYSPHAGIA 6 0.0001
636 HEAD INJURY 2 0.0001
637 FALL 21 0.0001
638 RESPIRATORY TRACT CONGESTION 1 0.0001
639 WEIGHT INCREASED 14 0.0001
640 INTENTIONAL OVERDOSE 4 0.0001
641 CARDIAC FAILURE 5 0.0001
642 RASH 27 0.0001
643 LACTIC ACIDOSIS 2 0.0001
644 MUSCULAR WEAKNESS 7 0.0001
645 SWELLING FACE 4 0.0001
646 LUNG DISORDER 3 0.0001
647 IMPAIRED HEALING 2 0.0001
648 VENTRICULAR TACHYCARDIA 1 0.0001
649 HYPOAESTHESIA 9 0.0001
650 COAGULOPATHY 1 0.0001
651 ABDOMINAL DISCOMFORT 10 0.0001
652 CELLULITIS 3 0.0001
653 EYE PRURITUS 2 0.0001
654 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
655 FACE OEDEMA 1 0.0001
656 CANDIDA INFECTION 1 0.0001
657 FLUID RETENTION 3 0.0001
658 BLOOD PRESSURE INCREASED 9 0.0001
659 URINARY TRACT INFECTION 10 0.0001
660 MUSCULOSKELETAL DISCOMFORT 1 0.0001
661 OEDEMA PERIPHERAL 7 0.0001
662 HEADACHE 36 0.0001
663 NERVOUSNESS 3 0.0001
664 RASH MACULAR 2 0.0001
665 DEVICE MALFUNCTION 4 0.0001
666 LYMPHOCYTE COUNT DECREASED 1 0.0001
667 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
668 LYMPHADENOPATHY 2 0.0001
669 HEAD DISCOMFORT 1 0.0001
670 DRUG ERUPTION 1 0.0001
671 GOUT 1 0.0001
672 FATIGUE 43 0.0001
673 BRONCHITIS 4 0.0001
674 AGRANULOCYTOSIS 1 0.0001
675 INFLUENZA 6 0.0001
676 HEPATIC STEATOSIS 1 0.0001
677 NECK PAIN 3 0.0001
678 PANCYTOPENIA 3 0.0001
679 HEPATIC FUNCTION ABNORMAL 2 0.0001
680 MIDDLE INSOMNIA 1 0.0001
681 ABDOMINAL PAIN UPPER 11 0.0001
682 SWELLING 5 0.0001
683 HEPATIC CIRRHOSIS 1 0.0001
684 CEREBROVASCULAR ACCIDENT 9 0.0001
685 FLATULENCE 3 0.0001
686 FRACTURE 1 0.0001
687 GASTRIC ULCER 1 0.0001
688 PROTEINURIA 1 0.0001
689 LETHARGY 3 0.0001
690 POST PROCEDURAL COMPLICATION 1 0.0001
691 SEROTONIN SYNDROME 1 0.0001
692 ACUTE RESPIRATORY FAILURE 1 0.0001
693 SEIZURE 6 0.0001
694 DRUG INTOLERANCE 5 0.0001
695 DYSPHONIA 3 0.0001
696 CHOKING 1 0.0001
697 BONE PAIN 3 0.0001
698 SURGERY 3 0.0001
699 SINUS DISORDER 1 0.0001
700 DISORIENTATION 2 0.0001
701 HAEMATOCRIT DECREASED 1 0.0001
702 PRESCRIBED UNDERDOSE 1 0.0001
703 FULL BLOOD COUNT DECREASED 1 0.0000
704 VERTIGO 3 0.0000
705 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
706 PRODUCT PREPARATION ERROR 1 0.0000
707 ERYTHEMA 10 0.0000
708 RIB FRACTURE 1 0.0000
709 INJECTION SITE WARMTH 1 0.0000
710 INFECTION 7 0.0000
711 TREMOR 8 0.0000
712 ARTHRALGIA 20 0.0000
713 RHABDOMYOLYSIS 2 0.0000
714 MALAISE 21 0.0000
715 ASTHENIA 18 0.0000
716 JOINT INJURY 1 0.0000
717 IMPAIRED WORK ABILITY 1 0.0000
718 DIARRHOEA 30 0.0000
719 POOR QUALITY SLEEP 1 0.0000
720 SKIN CANCER 1 0.0000
721 FAECES DISCOLOURED 1 0.0000
722 SEPTIC SHOCK 2 0.0000
723 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
724 ANGIOEDEMA 2 0.0000
725 STEVENS-JOHNSON SYNDROME 1 0.0000
726 TRANSAMINASES INCREASED 1 0.0000
727 THROMBOCYTOPENIA 5 0.0000
728 PULMONARY OEDEMA 2 0.0000
729 ORAL PAIN 1 0.0000
730 RASH PAPULAR 1 0.0000
731 SNEEZING 1 0.0000
732 PARAESTHESIA 7 0.0000
733 CHROMATURIA 1 0.0000
734 HEART RATE IRREGULAR 1 0.0000
735 MUSCLE SPASMS 8 0.0000
736 TINNITUS 2 0.0000
737 HYPOKALAEMIA 2 0.0000
738 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
739 OROPHARYNGEAL PAIN 4 0.0000
740 BACK PAIN 10 0.0000
741 COUGH 12 0.0000
742 PALPITATIONS 5 0.0000
743 SLEEP DISORDER 3 0.0000
744 HYPERTENSION 9 0.0000
745 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
746 COMA 2 0.0000
747 PRODUCTIVE COUGH 2 0.0000
748 BLOOD PRESSURE FLUCTUATION 1 0.0000
749 JOINT SWELLING 5 0.0000
750 FIBROMYALGIA 1 0.0000
751 UNDERDOSE 3 0.0000
752 LIVER INJURY 1 0.0000
753 DYSPEPSIA 4 0.0000
754 MYOCARDIAL INFARCTION 7 0.0000
755 EPISTAXIS 3 0.0000
756 PNEUMONIA ASPIRATION 1 0.0000
757 SYNCOPE 4 0.0000
758 UNEVALUABLE EVENT 3 0.0000
759 ACNE 3 0.0000
760 CHRONIC KIDNEY DISEASE 3 0.0000
761 GASTRIC CANCER 1 0.0000
762 PRODUCT COMPLAINT 1 0.0000
763 ANAPHYLACTIC SHOCK 1 0.0000
764 UNRESPONSIVE TO STIMULI 1 0.0000
765 ANXIETY 11 0.0000
766 EXPOSURE VIA SKIN CONTACT 1 0.0000
767 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
768 ABDOMINAL DISTENSION 4 0.0000
769 DEAFNESS 1 0.0000
770 SPEECH DISORDER 2 0.0000
771 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
772 PANCREATITIS 2 0.0000
773 DRUG INTERACTION 6 0.0000
774 CHEST PAIN 7 0.0000
775 EAR INFECTION 1 0.0000
776 DEHYDRATION 5 0.0000
777 THROMBOSIS 3 0.0000
778 THROAT TIGHTNESS 1 0.0000
779 OFF LABEL USE 32 0.0000
780 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
781 DIVERTICULITIS 1 0.0000
782 OXYGEN SATURATION DECREASED 2 0.0000
783 ASTHMA 4 0.0000
784 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
785 PAIN IN JAW 1 0.0000
786 MYALGIA 6 0.0000
787 INTENTIONAL DOSE OMISSION 1 0.0000
788 PRODUCT SUBSTITUTION ISSUE 2 0.0000
789 ABDOMINAL PAIN 8 0.0000
790 PAIN IN EXTREMITY 10 0.0000
791 TACHYCARDIA 3 0.0000
792 RENAL INJURY 1 0.0000
793 DEVICE ISSUE 3 0.0000
794 PREMATURE BABY 1 0.0000
795 APHASIA 1 0.0000
796 STOMATITIS 2 0.0000
797 PLEURAL EFFUSION 2 0.0000
798 EPILEPSY 1 0.0000
799 FEELING HOT 2 0.0000
800 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
801 DRUG-INDUCED LIVER INJURY 1 0.0000
802 DYSPNOEA 18 0.0000
803 MOOD SWINGS 1 0.0000
804 HYPOTHYROIDISM 1 0.0000
805 HIP FRACTURE 1 0.0000
806 NIGHT SWEATS 1 0.0000
807 ATRIAL FIBRILLATION 3 0.0000
808 FEBRILE NEUTROPENIA 2 0.0000
809 VISUAL ACUITY REDUCED 1 0.0000
810 INSOMNIA 8 0.0000
811 FUNGAL INFECTION 1 0.0000
812 SKIN DISORDER 1 0.0000
813 TYPE 2 DIABETES MELLITUS 1 0.0000
814 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
815 FLUSHING 3 0.0000
816 GASTRIC DISORDER 1 0.0000
817 HYPERKALAEMIA 1 0.0000
818 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
819 PLATELET COUNT DECREASED 3 0.0000
820 THERAPY INTERRUPTED 2 0.0000
821 CEREBRAL HAEMORRHAGE 1 0.0000
822 PNEUMONIA 9 0.0000
823 ACCIDENTAL OVERDOSE 1 0.0000
824 RESTLESSNESS 1 0.0000
825 NASOPHARYNGITIS 5 0.0000
826 DYSGEUSIA 2 0.0000
827 PRODUCT USE ISSUE 5 0.0000
828 DYSARTHRIA 1 0.0000
829 HALLUCINATION 2 0.0000
830 ACUTE KIDNEY INJURY 4 0.0000
831 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
832 PLASMA CELL MYELOMA 1 0.0000
833 ABORTION SPONTANEOUS 1 0.0000
834 CONFUSIONAL STATE 4 0.0000
835 NEUTROPHIL COUNT DECREASED 1 0.0000
836 INFLUENZA LIKE ILLNESS 2 0.0000
837 TREATMENT FAILURE 2 0.0000
838 WITHDRAWAL SYNDROME 1 0.0000
839 SKIN EXFOLIATION 2 0.0000
840 OSTEOARTHRITIS 1 0.0000
841 RECTAL HAEMORRHAGE 1 0.0000
842 MENTAL DISORDER 1 0.0000
843 INTENTIONAL PRODUCT MISUSE 2 0.0000
844 DRY SKIN 3 0.0000
845 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
846 ADVERSE DRUG REACTION 2 0.0000
847 THERAPY NON-RESPONDER 1 0.0000
848 SKIN DISCOLOURATION 1 0.0000
849 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
850 BREAST CANCER 2 0.0000
851 BLOOD CHOLESTEROL INCREASED 1 0.0000
852 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
853 ARRHYTHMIA 1 0.0000
854 OCULAR HYPERAEMIA 1 0.0000
855 DISEASE RECURRENCE 1 0.0000
856 RENAL CANCER 1 0.0000
857 ANAEMIA 4 0.0000
858 RASH ERYTHEMATOUS 1 0.0000
859 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
860 INTERSTITIAL LUNG DISEASE 1 0.0000
861 ALOPECIA 4 0.0000
862 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
863 LEUKOPENIA 1 0.0000
864 CHEST DISCOMFORT 2 0.0000
865 HAEMOGLOBIN DECREASED 2 0.0000
866 ECZEMA 1 0.0000
867 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
868 RASH PRURITIC 1 0.0000
869 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
870 TREATMENT NONCOMPLIANCE 1 0.0000
871 HYPONATRAEMIA 1 0.0000
872 DEPRESSION 4 0.0000
873 CHILLS 2 0.0000
874 IRRITABILITY 1 0.0000
875 NO ADVERSE EVENT 3 0.0000
876 EXPOSURE DURING PREGNANCY 1 0.0000
877 RHINORRHOEA 1 0.0000
878 AMNESIA 1 0.0000
879 BLOOD CREATININE INCREASED 1 0.0000
880 PSORIASIS 2 0.0000
881 DEATH 13 0.0000
882 RENAL FAILURE 2 0.0000
883 HYPOTENSION 3 0.0000
884 NEUTROPENIA 2 0.0000
885 PYREXIA 5 0.0000
886 INJURY 1 0.0000
887 SKIN BURNING SENSATION 1 0.0000
888 RESPIRATORY FAILURE 1 0.0000
889 AGITATION 1 0.0000
890 HOSPITALISATION 2 0.0000
891 DRUG DOSE OMISSION BY DEVICE 1 0.0000
892 PROSTATE CANCER 1 0.0000
893 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
894 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
895 MUSCULOSKELETAL STIFFNESS 1 0.0000
896 SUICIDAL IDEATION 1 0.0000
897 CARDIAC DISORDER 1 0.0000
898 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
899 RHEUMATOID ARTHRITIS 1 0.0000
900 DISEASE PROGRESSION 1 0.0000
901 EMOTIONAL DISTRESS 1 0.0000
902 PRODUCT QUALITY ISSUE 1 0.0000
903 CONDITION AGGRAVATED 2 0.0000